2G-Regel

Last updated
Government infographic describing the 2G rule. Schild 2G-plus-Regel.png
Government infographic describing the 2G rule.

In Germany, the 2G rule (2G-Regel) refers to public health rules during the COVID-19 pandemic for vaccinated (German: geimpft) or recovered (German: genesen) people.

Contents

More restrictive versions are the 2G+ (additionally requiring a rapid test) and the 2G++ rules (additionally requiring a rapid test and the wearing of an FFP2 Mask). 3G is less restrictive in that any testing would supersede, rather than complement, the other two requirements ("vaccinated or recovered"). [1] [2] All tests must have been administered at an official test site.

Objective

The special protective measures (§ 28a IfSG) of the Protection Against Infection Act  [ de ] are authorized to prevent the spread of COVID-19.[ citation needed ]

Definitions

Fully vaccinated

In Germany, until October 2022, according to the Robert Koch Institute, a person is considered "fully vaccinated", who:[ citation needed ]

Recovered

Note on the applicable 2G rules in front of a clothing store 2G-Hinweisschild bei OLYMP&HADES 20211222 122529.jpg
Note on the applicable 2G rules in front of a clothing store

"Recovered" in Germany in this context means someone who:[ citation needed ]

Current case law

Judgments for retail

For the 2G retail scheme, there was a "2G dispute" between the Federal Government and different trade associations. The Federal Government stressed adherence to the measures, while trade associations argued that the measures are inappropriate. Different retail companies had complained in a row in several federal states against the 2G regulation.[ citation needed ]

Schleswig-Holstein

The Schleswig-Holstein Upper Administrative Court  [ de ] had rejected the urgent application of a department store company against the 2G regulation on 15 December and followed in its judgment of politics. The court saw the 2G regulations considered appropriately and suited to prevent the "worrying" dissemination of the omicron variant. The OVG also approved the distinction between transactions in which 2G applies and transactions of basic care in which the measures are excluded than justifiable. The court in Lower Saxony, however, has seen a violation of the principle of equality in this distinction.[ citation needed ]

Lower Saxony

On 17 December 2021, the Upper Administrative Court at Lüneburg decided that the 2G rule violates the principle of equality and is not allowed to be applied for the time being in Lower Saxony. The judgment of the 13th Senate says that politics can not transfer research results from the sports and leisure sector to retail research, because FFP2 masks could be worn in shops. It was incomprehensible to the court that the government did not create its own studies to increase the "target accuracy of their protective measures".[ citation needed ]

Department store chain Woolworth in Schleswig-Holstein and Lower Saxony had complained against the regulation. A spokeswoman for the company stressed that the 2G rule is discriminatory and the retail sector proved to be no pandemic driver. In a press release of the DPA was claimed, it would now be a nationwide implementation of the 3G rule  [ de ] conceivable. "Shopowners can make use of their house right and continue to limit the inlet. Now it has to be clarified as the state government will regulate this area in the corresponding Corona Regulation."[ citation needed ]

Prime Minister Stephan Weil expressed his incomprehension at the verdict and pointed out that the Upper Administrative Court in Schleswig-Holstein had confirmed the 2G regulation on the same day. Lower Saxony is thus the only state in which 2G should no longer be used for the time being. The Federal Government confirmed, also adhering to the 2G measures and to continue this "meaningful measures" within the framework of the Infection Protection Act. Minister of Health Karl Lauterbach "(...) said after the joint appointment with because in Hanover, the 2G rule is useful. So 2g in retail also 'very much more effective than a mask obligation."[ citation needed ]

Bavaria

As of 8 December 2021, the Bavarian State Government rejected the federal state decisions of 2 December 2021 and stated that in all transactions that are not counted on "business of daily necessities" 2G. Except for this were: food and beverage trading, drugstores, pharmacies, construction and garden markets, bookstores, letter and mail order, press and tobacco, petrol stations, flower shops et al.

According to the judgment on the annulment of the 2G regulation in the retail trade in Lower Saxony, Bavarian Minister of Health Klaus Holetschek  [ de ] confirmed to stick to the 2G regulations in the Bavarian retail trade. One argued that the Bavarian state government was no easing for retail in view of the major threat by the omicron variant and "full intensive stations". Klaus Josef Lutz, the President of the Bavarian Chamber of Commerce and Chamber of Commerce, in the judgment in Lower Saxony, on the other hand, saw an important signal: "Confederation and countries should finish 2G in retail. It should be allowed to open all stores unrestricted again - of course with distance, masks and hygiene concept. The protection of customers and staff will and must continue to be guaranteed."

On 21 December, the Bavarian Constitutional Court decided to suspend the 2G regulation for toy transactions. It now also includes the "shops of daily necessities", which are excluded from 2G. The judges justified their verdict that toy transactions for children "(...) had the same meaning as adult books, cut flowers and garden tools (...)". "How important and urgently needed a daily need so that the business is not subject to the 2G regulation, neither the regulation text nor the justification can be found." The verdict is final.[ citation needed ]

Thuringia

In the next few weeks, the Upper Administrative Court in Weimar will deal with the 2G regulation in retail.[ citation needed ]

Berlin and Brandenburg

In Berlin, Galeria Karstadt Kaufhof GmbH had complained against the current 2G regulations. Next week, the company wants to submit another complaint in Brandenburg.

Judgments for universities

Baden-Württemberg

On 17 December, it became known that an unvaccinated pharmacy student opposed to the 2G regulations had succeeded. "The Pharmaceutical Student, who had submitted the urgent application, was not vaccinated by the information and needed to successfully implement his studies access to premises and the infrastructure of the university. It must participate in certain presence events in order not to exceed his studies and exceeded become."

The Mannheim (VGH)  [ de ] already set the measures in the state on 15 December out of progress. The court justified its decision that the student could no longer deserve due to the 2G regulations of the obligation to increase in his degree program and the universities were not required to continue to enable non vaccinated students to participate in their studies. The decision of the VGH is final.

Related Research Articles

A breakthrough infection is a case of illness in which a vaccinated individual becomes infected with the illness, because the vaccine has failed to provide complete immunity against the pathogen. Breakthrough infections have been identified in individuals immunized against a variety of diseases including mumps, varicella (Chickenpox), influenza, and COVID-19. The characteristics of the breakthrough infection are dependent on the virus itself. Often, infection of the vaccinated individual results in milder symptoms and shorter duration than if the infection were contracted naturally.

<span class="mw-page-title-main">COVID-19 pandemic in Germany</span> Ongoing COVID-19 viral pandemic in Germany

The COVID-19 pandemic in Germany has resulted in 38,368,891 confirmed cases of COVID-19 and 171,411 deaths.

<span class="mw-page-title-main">COVID-19 pandemic in Austria</span> Ongoing COVID-19 viral pandemic in Austria

The COVID-19 pandemic in Austria is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. In Austria, a pair of cases were confirmed on 25 February 2020. The cases involved a 24-year-old man and a 24-year-old woman who were travelling from Lombardy, Italy, and were treated at a hospital in Innsbruck. According to new figures released by Austrian authorities on 23 June, the first case in the country was recorded in Ischgl, Tyrol on 8 February.

<span class="mw-page-title-main">COVID-19 pandemic in Latvia</span> Ongoing COVID-19 viral pandemic in Latvia

The COVID-19 pandemic in Latvia is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Latvia on 2 March 2020, having been brought along with people returning from abroad.

<span class="mw-page-title-main">COVID-19 pandemic in Egypt</span> Ongoing COVID-19 viral pandemic in Egypt

The COVID-19 pandemic in Egypt is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Egypt on 14 February 2020.

<span class="mw-page-title-main">COVID-19 vaccine</span> Vaccine designed to provide acquired immunity against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).

The COVID-19 pandemic was confirmed to have reached Cyprus on 9 March 2020. Data released by the Cypriot government includes cases in the British Overseas Territory of Akrotiri and Dhekelia, but does not include cases in Northern Cyprus due to the long-running Cyprus dispute.

<span class="mw-page-title-main">COVID-19 pandemic in Cuba</span> Ongoing COVID-19 viral pandemic in Cuba

The COVID-19 pandemic in Cuba is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have spread to Cuba on 11 March 2020 when three Italian tourists tested positive for the virus.

<span class="mw-page-title-main">COVID-19 pandemic in the Cook Islands</span> COVID-19 viral pandemic in the Cook Islands

The COVID-19 pandemic in the Cook Islands is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. As of 30 October 2021, 12,841 first doses and 12,498 second doses of vaccine had been administered, which represents over 97% of the eligible population (12+) fully vaccinated.

The following is a timeline of the COVID-19 pandemic in the Republic of Ireland in 2021.

<span class="mw-page-title-main">COVIran Barekat</span> COVIran Barakat vaccine against COVID-19

COVIran Barekat is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical Group. It is an inactivated virus-based vaccine. Iranian authorities have authorized its emergency use. This makes it the first locally developed COVID-19 vaccine to be approved for emergency use in the Middle East.

<span class="mw-page-title-main">EpiVacCorona</span> EpiVacCorona vaccine against COVID-19

EpiVacCorona is a peptide-based vaccine against COVID-19 developed by the VECTOR center of Virology. The lack of protective effectiveness of EpiVacCorona, which is still in use in Russia, has been reported in scientific literature and in the media. The vaccine consists of three chemically synthesized peptides that are conjugated to a large carrier protein. This protein is a fusion product of a viral nucleocapsid protein and a bacterial MBP protein. A phase three clinical trial to show whether or not the vaccine can protect people against COVID-19 was launched in November 2020 with more than three thousand participants. The facts of the end of the trial and the result of the trial have not been made public.

<span class="mw-page-title-main">COVID-19 vaccination in New Zealand</span> Ongoing COVID-19 vaccine programme in New Zealand

COVID-19 vaccination in New Zealand began on 20 February 2021, and will continue throughout the pandemic with the goal of vaccinating all willing New Zealanders aged 5 or older. Those aged 5 to 11 require a parent, caregiver or legal guardian accompany them to their appointment and provide consent for them to be vaccinated. As of 1 September, anyone in New Zealand, regardless of their immigration status, is eligible to be vaccinated.

<span class="mw-page-title-main">SARS-CoV-2 Delta variant</span> Variant of SARS-CoV-2 detected late 2020

The Delta variant (B.1.617.2) was a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in India on 5 October 2020. The Delta variant was named on 31 May 2021 and had spread to over 179 countries by 22 November 2021. The World Health Organization (WHO) indicated in June 2021 that the Delta variant was becoming the dominant strain globally.

COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccine clinical research</span>

COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy, effectiveness and safety. As of November 2022, 40 vaccines are authorized by at least one national regulatory authority for public use:

<span class="mw-page-title-main">COVID-19 vaccine misinformation and hesitancy</span> Misinformation regarding the SARS-CoV-2 vaccine and the resulting hesitancy towards it

Anti-vaccination activists and other people in many countries have spread a variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines based on misunderstood or misrepresented science, religion, and law. These have included exaggerated claims about side effects, misrepresentations about how the immune system works and when and how COVID-19 vaccines are made, a story about COVID-19 being spread by 5G, and other false or distorted information. This misinformation has proliferated and may have made many people averse to vaccination. This has led to governments and private organizations around the world introducing measures to incentivize/coerce vaccination, such as lotteries, mandates and free entry to events, which has in turn led to further misinformation about the legality and effect of these measures themselves.

<span class="mw-page-title-main">Vaccine passports during the COVID-19 pandemic</span> Use of immunity passports for COVID-19 vaccination

A vaccine passport or proof of vaccination is an immunity passport employed as a credential in countries and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health authority, and usually consists of a digital or printed record. Some credentials may include a scannable QR code, which can also be provisioned via mobile app. It may or may not use a COVID-19 vaccine card as a basis of authentication.

<span class="mw-page-title-main">German government response to the COVID-19 pandemic</span> Actions by the German government on COVID-19 pandemic

The government of Germany has initially responded to the COVID-19 pandemic in the country with preventive measures to curb the spread of the coronavirus disease 2019 in the country. With the nationwide spread of the disease from March 2020, preventive measures were replaced by containment measures, including a lockdown from March. On 25 March, the Bundestag made the determination of an epidemic situation of national significance. This created a legal framework for the government of chancellor Angela Merkel and the heads of the 16 German states to agree on nationwide pandemic restrictions. Implementation of decisions by that panel remained a matter of individual states, however, leading to differences in anti-pandemic rules and regulations across states.

<span class="mw-page-title-main">SARS-CoV-2 Omicron variant</span> Type of the virus first detected in November 2021

Omicron (B.1.1.529) is a variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South Africa on 24 November 2021. It was first detected in Botswana and has spread to become the predominant variant in circulation around the world. Following the original B.1.1.529 variant, several subvariants of Omicron have emerged including: BA.1, BA.2, BA.3, BA.4, and BA.5. Since October 2022, two subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged.

References

  1. "Covid: Germany puts major restrictions on unvaccinated". BBC News. 2021-12-02. Retrieved 2022-01-02.
  2. Brady, Kate (2021-11-16). "Berlin tightens COVID-19 rules for unvaccinated | DW | 16.11.2021". Deutsche Welle . Archived from the original on 2021-11-16. Retrieved 2022-01-02.